|Bid||2.3500 x 0|
|Ask||2.4000 x 0|
|Day's Range||2.2700 - 2.3600|
|52 Week Range||2.1500 - 7.5000|
|Beta (5Y Monthly)||0.82|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
GUELPH, ON /ACCESSWIRE / June 6, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce that on March 28, 2022, the Canadian national phase was initiated for its patent application directed to its ZenGUARD™ technology.
GUELPH, ON / ACCESSWIRE / June 1, 2022 / Zentek Ltd. ("Zentek" or the "Company" or the "Corporation") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, has retained Halteres Associates ("Halteres"), a leading consultancy focused on global health, diagnostics, and point-of-care testing, to help with commercialization of the aptamer-based rapid detection technology exclusively licensed by Zentek pursuant to its licence agreement dated April 11, 2021 with